510(k) K014101
K014101 is an FDA 510(k) premarket notification submitted by American Bio Medica Corp. for the device "RAPIDONE-OXY TEST". The FDA issued a decision of Substantially Equivalent on Mar 20, 2002. The device falls under product code DJG (Enzyme Immunoassay, Opiates), a Class II device regulated under 21 CFR 862.3650. American Bio Medica Corp. has 29 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 20, 2002
- Date Received
- Dec 13, 2001
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Opiates
- Device Class
- Class II
- Regulation Number
- 862.3650
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for American Bio Medica Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.